Overall Survival in Metastatic Breast Cancer Patients in the Third Millennium: Results of the COSMO Study

Nicla La Verde, Elena Collovà, Livio Blasi, Graziella Pinotti, Raffaella Palumbo, Marta Bonotto, Ornella Garrone, Antonella Brunello, Anita Rimanti, Claudia Bareggi, Alberto Zaniboni, Antonio Frassoldati, Jennifer Foglietta, Rossana Berardi, Anna Moretti, Gabriella Farina, Luca Porcu, Sandro Barni

Research output: Contribution to journalArticlepeer-review

Abstract

Metastatic breast cancer remains a deadly disease despite scientific progress. The COSMO study included 3721 patients and aimed to detect a temporal variation in overall survival during the period 2000-2008 that had not yet been demonstrated. Disease-free interval, metastatic site, age at diagnosis, and tumor biology remain important factors that affect prognosis.

Original languageEnglish
Pages (from-to)1-8
Number of pages8
JournalClinical Breast Cancer
DOIs
Publication statusE-pub ahead of print - Nov 9 2020

Keywords

  • Biological subtype
  • Bone disease
  • Breast cancer prognosis
  • Disease free interval
  • Visceral disease

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Overall Survival in Metastatic Breast Cancer Patients in the Third Millennium: Results of the COSMO Study'. Together they form a unique fingerprint.

Cite this